How is neuropathic cancer pain assessed in randomised controlled trials?

Pain

Volumn 153, Issue 1, 2012, Pages 13-17

  Kurita, Geana Paula ^a,b   Ulrich, Angelika ^c   Jensen, Troels Staehelin ^d   Werner, Mads Utke ^a   Sjøgren, Per ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c LILLEBAELT HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; GABAPENTIN; IMIPRAMINE; KETAMINE; LIDOCAINE; NAPROXEN; TRAMADOL;

ADVANCED CANCER; CANCER PAIN; CLINICAL FEATURE; DISEASE SEVERITY; HUMAN; NEUROPATHIC PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PLACEBO EFFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

HUMANS; NEOPLASMS; NEURALGIA; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84155167286     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2011.08.013     Document Type: Review

References (31)

1. Y.C. Arai, T. Matsubara, K. Shimo, K. Suetomi, M. Nishihara, T. Ushida, K. Kobayashi, C. Suzuki, A. Kinoshita, M. Kondo, S. Matsubara, R. Hayashi, Y. Tohyama, K. Nishida, and M. Arakawa Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine J Anesth 24 2010 407 410
2. D. Arbaiza, and O. Vidal Tramadol in the treatment of neuropathic cancer pain. A double-blind, placebo-controlled study Clin Drug Investig 27 2007 75 83 (Pubitemid 46058736)
3. N. Attal, G. Cruccu, M. Haanpää, P. Hansson, T.S. Jensen, T. Nurmikko, C. Sampaio, S. Sindrup, P. Wiffen EFNS Task Force EFNS guidelines on pharmacological treatment of neuropathic pain Eur J Neurol 13 2006 1153 1169 (Pubitemid 44581463)
4. R. Baron, T.R. Tölle, U. Gockel, M. Brosz, and R. Freynhagen A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms Pain 146 2009 34 40
5. M. Bennett The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs Pain 92 2001 147 157 (Pubitemid 32367946)
6. D. Bouhassira, N. Attal, J. Fermanian, H. Alchaar, M. Gautron, E. Masquelier, S. Rostaing, M. Lanteri-Minet, E. Collin, J. Grisart, and F. Boureau Development and validation of the Neuropathic Pain Symptom Inventory Pain 108 2004 248 257 (Pubitemid 38353047)
7. E. Bruera, C. Ripamonti, C. Brenneis, K. Macmillan, and J. Hanson A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain J Pain Symptom Manage 7 1992 138 140
8. E. Bruera, T. Schoeller, R. Wenk, T. MacEachern, S. Marcelino, J. Hanson, and M. Suarez-Almazor A prospective multicenter assessment of the Edmonton staging system for cancer pain J Pain Symptom Manage 10 1995 348 355
9. A. Caraceni, and R.K. Portenoy An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain Pain 82 1999 263 274
10. A. Caraceni, E. Zecca, C. Bonezzi, E. Arcuri, R. Yaya Tur, M. Maltoni, M. Visentin, G. Gorni, C. Martini, W. Tirelli, M. Barbieri, and F. De Conno Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group J Clin Oncol 22 2004 2909 2917 (Pubitemid 41079911)
11. G. Cruccu, C. Sommer, P. Anand, N. Attal, R. Baron, L. Garcia-Larrea, M. Haanpää, T.S. Jensen, and R.D. Treede EFNS guidelines on neuropathic pain assessment: revised 2009 Eur J Neurol 17 2010 1010 1018
12. P.L. Dellemijn, H.B. Verbiest, J.J. van Vliet, P.J. Roos, and C.J. Vecht Medical therapy of malignant nerve pain. A randomized double-blind explanatory trial with naproxen versus slow-release morphine Eur J Cancer 30 1994 1244 1250 (Pubitemid 24322055)
13. K. Ellemann, P. Sjøgren, A.M. Banning, T.S. Jensen, T. Smith, and P. Geertsen Trial of intravenous lidocaine on painful neuropathy in cancer patients Clin J Pain 5 1989 291 294 (Pubitemid 20054145)
14. R. Freynhagen, R. Baron, U. Gockel, and T.R. Tölle painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain Curr Med Res Opin 22 2006 1911 1920 (Pubitemid 44663395)
15. B.S. Galer, and M.P. Jensen Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale Neurology 48 1997 332 338 (Pubitemid 27087598)
16. S. Grond, L. Radbruch, T. Meuser, R. Sabatowski, G. Loick, and K.A. Lehmann Assessment and treatment of neuropathic cancer pain following WHO guidelines Pain 79 1999 15 20 (Pubitemid 29012430)
17. M. Haanpää, and R.D. Treede Diagnosis and classification of neuropathic pain Pain Clin Updates 18 2010 1 6
18. M.P. Jensen, A.R. Gammaitoni, D.O. Olaleye, N. Oleka, S.R. Nalamachu, and B.S. Galer The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome J Pain 7 2006 823 832 (Pubitemid 44740532)
19. K. Keskinbora, A.F. Pekel, and I. Aydinli Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial J Pain Symptom Manage 34 2007 183 189 (Pubitemid 47088905)
20. S. Mercadante, E. Arcuri, W. Tirelli, and A. Casuccio Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study J Pain Symptom Manage 20 2000 246 252
21. S. Mercadante, E. Arcuri, W. Tirelli, P. Villari, and A. Casuccio Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study Tumori 88 2002 239 242 (Pubitemid 34875452)
22. H. Merskey, and N. Bogduk Classification of chronic pain 1994 IASP Press Seattle 209 214
23. Oxford Centre for Evidence-based Medicine. Asking focused questions. Available from: http://www.cebm.net/index.aspx?o=1036.
24. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, Dawes M. Oxford Centre for Evidence-based Medicine - levels of evidence. Available from: http://www.cebm.net/?o=1025.
25. R.K. Portenoy, K.M. Foley, and C.E. Inturrisi The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions Pain 43 1990 273 286
26. R.K. Portenoy, D. Payne, and P. Jacobsen Breakthrough pain: characteristics and impact in patients with cancer pain Pain 81 1999 129 134 (Pubitemid 29199908)
27. G. Rinck, J. Kleijnen, T.G. Van den Bos, H.J. de Haes, E. Schade, and C.H. Veenhof Trials in palliative care BMJ 310 1995 598 599
28. R.D. Searle, and M. Bennett The management of neuropathic pain in cancer Prog Palliat Care 16 2008 7 13
29. R.D. Treede, T.S. Jensen, J.N. Campbell, G. Cruccu, J.O. Dostrovsky, J.W. Griffin, P. Hansson, R. Hughes, T. Nurmikko, and J. Serra Neuropathic pain Neurology 70 2008 1630 1635
30. C.J. Woolf Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy Life Sci 74 2004 2605 2610 (Pubitemid 38369357)
31. C.J. Woolf, and R.J. Mannion Neuropathic pain: aetiology, symptoms, mechanisms, and management Lancet 353 1999 1953 1964